搜索

Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS
Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS
Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS
Ab&B Bio-Tech CO.,LTD.JS Ab&B Bio-Tech CO.,LTD.JS

Why Choose Us?

Let China use globally innovative vaccines, and let the world use high-quality vaccines from China!

quanfu quanfu

Strong Corporate Strength

Ab&B Bio-Tech CO.,LTD.JS has a registered capital of 360 million yuan, a total area of 173 acres, and a total construction area of 228000 square meters. The No.1 production park covers an area of 69 acres, with a building area of 80000 square meters and a project investment of 1 billion yuan; The second production park covers an area of 72 acres, with a building area of 120000 square meters and a project investment of 2 billion yuan; The No. 3 Production Park covers an area of 32 acres, with a building area of 28000 square meters and a project investment of 600 million yuan

quanfu quanfu

Products & Services

Committed to the research and development, registration and application, industrial production and sales of innovative vaccines for human use, targeting international standards, and conducting independent innovative research and development.

quanfu quanfu

Scientific Research Capability

Shanghai/Taizhou R&D Center and pilot platform are promoting multiple viral vaccines, bacterial vaccines, conjugate vaccines, recombinant subunit vaccines, and mRNA vaccine pipelines simultaneously.

Product Pipelines

Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio

Quadrivalent Subunit Influenza Vaccine（0.5ml）

Quadrivalent Subunit Influenza Vaccine（0.5ml）

This strain is made by inoculating chicken embryos with type A and type B influenza virus strains recommended by the World Health Organization (WHO), after cultivation, harvesting virus liquid, ultrafiltration concentration, virus splitting centrifugation, purification, virus inactivation, and then purifying and harvesting haemagglutinin and neuraminidase.

More Product Series

News Center

Ab&B Bio and Yither Bio have both obtained qualification certification!
2024-12-30

Recently,  Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively.
→

The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held
2024-12-25

Recently, the clinical launch meeting for the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome, in collaboration with Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） was successfully held at the research site in Guangdong. This clinical study is sponsored and conducted by Guangzhou Women and Children's Medical Center as the core research unit, aiming to provide evidence-based influenza vaccination for children with nephrotic syndrome as a special group, in order to reduce their risk of influenza virus infection and severe infection.
→

Influenza virus subunit vaccine (adjuvant) IND application approved
2024-10-30

Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio）and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) jointly applied for a Class I new drug "Influenza Virus Subunit Vaccine (Adjuvant)" IND application, which has been approved by the Drug Evaluation Center (CDE) of the China National Medical Products Administration. The approval of this vaccine marks the completion of the full coverage of the company's subunit influenza vaccine product pipeline for trivalent and quadrivalent influenza virus subunit vaccines, providing the most accurate selection for different age groups and different demand groups.
→

Have a project？Get a touch!

Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio

Contact

E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City

Quick view

Follow us

Copyright © 2022 Ab&B Bio-Tech CO.,LTD.JS All Rights Reserved.   Powered by:www.300.cn
Verification 苏ICP备16005775号-1
Search